Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03096548 · ClinicalTrials.gov registry record · NA
Sun Safety Ink! A Sun Safety Program for the Tattoo Community
A NA study, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 1,820
- Enrollment target
NCT03096548 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 1,820 participants.
The verdict
NCT03096548, a NA study, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,820 participants
- Enrollment target
Study Summary
Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo studios because tattoo aftercare recommendations can include sun protection for tattoos, and studios offer an opportunity to reach younger adults who are significantly more likely to sunburn and less likely to practice sun safety. The study will assess the effectiveness of SSI! at (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Sun Safety Ink! Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03096548
The ClinicalTrials.gov registry entry for NCT03096548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,820 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Klein Buendel, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT03096548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03096548 about?
NCT03096548 is a clinical study titled "Sun Safety Ink! A Sun Safety Program for the Tattoo Community". Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo ...
What is the current status of trial NCT03096548?
This trial is currently completed. It is a NA study. The enrollment target is 1,820 participants. The study started on 2017-06-15. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03096548?
The interventions under investigation include: Attention Control (BEHAVIORAL), Sun Safety Ink! Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03096548?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.